Gene · 4610
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. | Cell Biol Toxicol | 2023 | 35953652 | PubTator, text mining | PubMed |
| BRD4 and MYC: power couple in transcription and disease. | FEBS J | 2023 | 35866356 | PubTator, text mining | PubMed |
| Whole exome analysis reveals the genomic profiling related to chemo-resistance in Chinese population with limited-disease small cell lung cancer. | Cancer Med | 2023 | 35735600 | PubTator, text mining | PubMed |
| Current therapy and development of therapeutic agents for lung cancer. | Cell Insight | 2022 | 37193130 | PubTator, text mining | PubMed |
| Tissue engineering in reconstructive urology-The current status and critical insights to set future directions-critical review. | Front Bioeng Biotechnol | 2022 | 36950181 | PubTator, text mining | PubMed |
| MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner. | Cancer Res Commun | 2022 | 36874405 | PubTator, text mining | PubMed |
| Primary breast angiosarcoma: A case report. | Front Surg | 2022 | 36873809 | PubTator, text mining | PubMed |
| Retinal ganglion cell-specific genetic regulation in primary open-angle glaucoma. | Cell Genom | 2022 | 36778138 | PubTator, text mining | PubMed |
| The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells? | Front Endocrinol (Lausanne) | 2022 | 36686451 | PubTator, text mining | PubMed |
| Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient. | Cancer Res Commun | 2022 | 36643868 | PubTator, text mining | PubMed |
| Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect. | Front Oncol | 2022 | 36620597 | PubTator, text mining | PubMed |
| Relationship between serum NDRG3 and papillary thyroid carcinoma. | Front Endocrinol (Lausanne) | 2022 | 36619553 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Identifies Drug-Resistance Signature and Immunosuppressive Microenvironment in Metastatic Small Cell Lung Cancer. | Adv Genet (Hoboken) | 2022 | 36618022 | PubTator, text mining | PubMed |
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors. | Cancers (Basel) | 2022 | 36612255 | PubTator, text mining | PubMed |
| Proteomic and Transcriptomic Landscapes of Alström and Bardet-Biedl Syndromes. | Genes (Basel) | 2022 | 36553637 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Identifies Master Regulators Affected by Panobinostat in Neuroblastoma Cells. | Genes (Basel) | 2022 | 36553506 | PubTator, text mining | PubMed |
| AP-2δ Is the Most Relevant Target of AP-2 Family-Focused Cancer Therapy and Affects Genome Organization. | Cells | 2022 | 36552887 | PubTator, text mining | PubMed |
| Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment. | Cancers (Basel) | 2022 | 36551697 | PubTator, text mining | PubMed |
| The Efficiency of Direct Maturation: the Comparison of Two hiPSC Differentiation Approaches into Motor Neurons. | Stem Cells Int | 2022 | 36530489 | PubTator, text mining | PubMed |
| Cell senescence-associated genes predict the malignant characteristics of glioblastoma. | Cancer Cell Int | 2022 | 36527013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4610/papers?page=19